Greenhill Nguyen Neg
| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| Heart of Texas Invitational | 2 | Immaculate Heart SS | Claudia Ribera |
|
|
| |
| Newman Smith | 2 | Coppell Delgado | Joseph Donawho |
|
|
| |
| Newman Smith | 4 | Coppell Karunadasa | Prateek Fulzele |
|
|
| |
| none | Finals | none | none |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| Heart of Texas Invitational | 2 | Opponent: Immaculate Heart SS | Judge: Claudia Ribera 1AC - CRISPR |
| Newman Smith | 2 | Opponent: Coppell Delgado | Judge: Joseph Donawho trad 1ac |
| Newman Smith | 4 | Opponent: Coppell Karunadasa | Judge: Prateek Fulzele 1ac - trad |
| none | Finals | Opponent: none | Judge: none sup |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
0 - Contact InfoTournament: none | Round: Finals | Opponent: none | Judge: none hi! i go by she/her pronouns, but i don't mind any pronouns. as a heads up, i would really prefer that you give a trigger warning for suicide. please let me know if you don’t have access to any articles/books i’ve got cards disclosed from and i’ll send you the full text! if you need any of my speech docs, please let me know and i’ll send ’em your way. | 9/24/21 |
SO21 - DA - Counterfeit MedicineTournament: Newman Smith | Round: 2 | Opponent: Coppell Delgado | Judge: Joseph Donawho SO21 – DA – Counterfeit DrugsHealthcare counterfeiting is on the rise, but national regulations in the status quo combat the problem for the WTO – IP is the goldilocks enabler for sustained cooperation.Author Diana Bentley in 2021, ("The insidious problem of counterfeiting in healthcare," Raconteur, https://www.raconteur.net/legal/intellectual-property/counterfeiting-healthcare/) KD IP is the key tool to prevent the spread of counterfeit medicines – the 1AC removes insurance measures for companies to have the necessary standards for developing high-quality medications.FIFARMA in 2021, Latin American Federation of Pharma Industry, represent 16 research-based biopharmaceutical companies and 11 local associations dedicated to discovering and developing innovative, quality and safe health products and services that improve the lives of patients in Latin America and the Caribbean and advocate for patient-centric, sustainable health systems characterized by high regulatory standards and ethical principles ("This is how we fight counterfeit medicines with Intellectual Property," https://fifarma.org/en/this-is-how-we-fight-counterfeit-medicines-with-intellectual-property/) KD Counterfeits inflate prices for market introductions and strengthen anti-microbial resistance – that's the key internal link to pandemicsBuckley and Gostin 13, Senior Program Officer at National Academies of Sciences, Engineering, and Medicine; Highest Academic Rank at Georgetown Law, American law professor who specializes in public health law. He was a Fulbright Fellow and is best known as the author of the Model State Emergency Health Powers Act and as a significant contributor to journals on medicine and law ("The Effects of Falsified and Substandard Drugs," https://www.ncbi.nlm.nih.gov/books/NBK202526/) KD AMR is the key internal link to sustained pandemics and causes biowarfareAMR - no herd immunity - longer-lasting and stronger pandemics Bioterrorism and future pandemics cause extinction.Hamish De Bretton-Gordon, CBRN Expert @ British Army, 20 ~Director @ DBG Defense, Consultant on CBRN and Biosecurity~, "Biosecurity in the Wake of COVID-19: The Urgent Action Needed," Combatting Terrorism Center Sentinel, November/December 2020, Volume 13, Issue 11, https://ctc.usma.edu/biosecurity-in-the-wake-of-covid-19-the-urgent-action-needed/ | 9/25/21 |
SO21 - DA - InnovationTournament: Newman Smith | Round: 2 | Opponent: Coppell Delgado | Judge: Joseph Donawho Innovation DAPharmaceutical RandD has skyrocketed after COVID – but sustained research relies on the strength of pharmaceutical plans.CBO 21, Congressional Budget Office, Non-partisan Analysis for US Congress (Research and Development in the Pharmaceutical Industry," Congressional Budget Office, https://www.cbo.gov/publication/57126) KD IP protections creates market power and funding to maximize production of live-saving medicines to vulnerable populationsKennedy 19, Joe Kennedy is a senior fellow at the Information Technology and Innovation Foundation. He focuses on economic policy. For almost three decades, he has provided legal and economic advice to senior officials in the public and private sector. Much of this advice has been directed at public policies involving technology, competitiveness, and the social contract. He also consults privately on these issues. Dr. Kennedy previously served as the chief economist for the U.S. Department of Commerce where he oversaw a staff of 15 economists and regularly briefed the secretary of commerce on economic issues including the financial crisis and immigration reform. He has held numerous other positions in government, serving on committees in both houses of Congress and in the executive branch. As senior counsel for the Senate Permanent Subcommittee on Investigations, he helped oversee investigations of the credit counseling industry, music downloading, and the United Nations Oil for Food Program. As senior economist for the Joint Economic Committee, he authored papers on telecommunications policy and nanotechnology. ("The Link Between Drug Prices and Research on the Next Generation of Cures," ITIF, https://itif.org/publications/2019/09/09/link-between-drug-prices-and-research-next-generation-cures) KD COVID proves pharma innovation saves lives – prevents future pandemics.Roberts 6-3-2021, senior director of the health and human services task force at the American Legislative Exchange Council; she previously served as campaign manager for Alabama Attorney General Luther Strange's successful re-election campaign. She holds a Juris Doctorate from the University of Alabama ("Pandemic proves importance of pharmaceutical innovation," TheHill, https://thehill.com/opinion/healthcare/556633-pandemic-proves-importance-of-pharmaceutical-innovation) KD | 9/25/21 |
SO21 - NC - Util FWTournament: Newman Smith | Round: 2 | Opponent: Coppell Delgado | Judge: Joseph Donawho FrameworkI negate Resolved: The member nations of the World Trade Organization ought to reduce intellectual property protections for medicines.I value morality, per the use of ought in the resolution, asking us to evaluate the moral obligations for both sides.Since the resolution asks nations to take an action, our frameworks in this debate should focus on government action.Governmental actors must be utilitarian, acknowledging that some policies will inevitably benefit some and harm others.Professor Woller in 1997, - (Gary ~Professor of Public Management, Brigham Young University~ "An Overview by Gary Woller" A Forum on the Role of Environmental Ethics, pg. 10) GHSGB Additionally, policy makers face moral uncertainty when making decisions since they are unsure of the ethical implications that their policy will have on each individual – as a result, they must make decisions that benefit the most people.Thus, my value criterion is maximizing expected well-being. | 9/25/21 |
SO21 - T - MedicineTournament: Heart of Texas Invitational | Round: 2 | Opponent: Immaculate Heart SS | Judge: Claudia Ribera T – MedicinesInterp – Medicines treat diseases. The aff must defend a reduction of IP protections for medicines.NLM ND, (US National Library of Medicine, "Medicines: MedlinePlus," https://medlineplus.gov/medicines.html) KD Violation – They defend CRISPR, which is a platform technology, not a medicine.Editas Medicine ~(a clinical-stage biotechnology company which is developing therapies based on CRISPR–Cas9 gene editing technology)., No Date, CRISPR Gene Editing, https://www.editasmedicine.com/crispr-gene-editing/~~ Net Benefits –Expanding the meaning of medicines lets them read plans about tons of medical inventions– CRISPR, vaccines, cannabis, all medical lab equipment, chemo, meditation, and tons of others—all of which have different members and governing structures. Two impacts – DTD on T – the debate shouldn't have happened if they were abusiveCompeting Interps on T since its binary and a question of models – Good enough isn't good—there can be no reasonable interp of what the topic actually meansNo RVIs on T – 1~ Illogical—T is a gateway issue, winning T is meeting a baseline to have the debate to begin with 2~ T is reactionary, they shouldn't win for meeting their preround burden 3~ Forcing the 1NC to go all in on theory kills substance education and neg flex—o/w on real world | 10/17/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|---|---|---|
9/25/21 | nguyene23@greenhillorg |
| |
9/25/21 | nguyene23@greenhillorg |
|